| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |